Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

55.58USD
24 Oct 2014
Price Change (% chg)

$1.53 (+2.83%)
Prev Close
$54.05
Open
$53.73
Day's High
$55.85
Day's Low
$53.50
Volume
259,369
Avg. Vol
226,477
52-wk High
$93.16
52-wk Low
$35.34

CLVS.OQ

Chart for CLVS.OQ

About

Clovis Oncology, Inc. (Clovis) is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer... (more)

Overall

Beta: --
Market Cap (Mil.): $1,887.72
Shares Outstanding (Mil.): 33.96
Dividend: --
Yield (%): --

Financials

  CLVS.OQ Industry Sector
P/E (TTM): -- 154.10 34.06
EPS (TTM): -3.53 -- --
ROI: -24.54 -1.61 17.45
ROE: -28.59 -6.70 18.26
Search Stocks

Competitors

  Price Change
Eisai Co., Ltd (4523.T) ¥4,250 +80.00
Pfizer Inc. (PFE.N) $29.11 +0.51
AstraZeneca plc (AZN.L) 4,327.50p -7.00
BioMarin Pharmaceutical Inc. (BMRN.OQ) $81.03 +6.02
TESARO Inc (TSRO.OQ) $28.10 +0.82
AbbVie Inc (ABBV.N) $60.29 +0.77
Novartis AG (NOVN.VX) CHF85.75 +0.35
Johnson & Johnson (JNJ.N) $103.13 +0.50
Eli Lilly and Co (LLY.N) $66.05 +1.70
GlaxoSmithKline plc (GSK.L) 1,415.50p +3.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks